Proteasome expression in the skeletal muscles of patients with muscular dystrophy
暂无分享,去创建一个
[1] T. Kumamoto,et al. Proteasomes in distal myopathy with rimmed vacuoles. , 1998, Internal medicine.
[2] T. Murakami,et al. Expression of three calpain isoform genes in human skeletal muscles , 1998, Journal of the Neurological Sciences.
[3] A. Engel,et al. Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain‐mediated proteolysis , 1997, Muscle & nerve.
[4] E. Kominami,et al. Calpain and cathepsins in the skeletal muscle of inflammatory myopathies. , 1997, European neurology.
[5] A. Goldberg,et al. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.
[6] S. E. Samuels,et al. No alteration in gene expression of components of the ubiquitin proteasome proteolytic pathway in dystrophin‐deficient muscles , 1996, FEBS letters.
[7] C. Guézennec,et al. Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. , 1996, The Biochemical journal.
[8] D. Breuillé,et al. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. , 1996, The Journal of clinical investigation.
[9] A. Goldberg,et al. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. , 1995, The Biochemical journal.
[10] A. Goldberg,et al. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. , 1995, The Biochemical journal.
[11] G. Tiao,et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. , 1994, The Journal of clinical investigation.
[12] I. Nonaka,et al. Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies , 1994, Neuromuscular Disorders.
[13] D. E. Goll,et al. Skeletal Muscle Proteases and Protein Turnover , 1989 .
[14] Hideo Sugita,et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide , 1988, Nature.
[15] Eric P. Hoffman,et al. Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.
[16] P. A. Reddy,et al. Calcium activated neutral proteases (milli- and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD). , 1986, Clinica chimica acta; international journal of clinical chemistry.
[17] J. Bodensteiner,et al. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies , 1978, Neurology.
[18] C. Pearson,et al. A calcium-activated neutral protease in normal and dystrophic human muscle. , 1976, Clinica chimica acta; international journal of clinical chemistry.